Bibliographie - 1420 - Stabilis 4.0

最新更新 :
27/11/2025

引用文献 1420

种类 :

文献

网络联接 :

https://doi.org/10.1046/j.1365-2710.1999.00208.x

研究小組 :

West Point - Merck and Co

作者 :

Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M.

标题 :

Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.

引用文献 :

J Clin Pharm Ther ; 24: 125-132. 1999

可信 :

物理稳定性 :

化学稳定性 :

High Performance Liquid Chromatography - ultraviolet detector (HPLC-UV)

其它方法 :

评论 :

稳定性指标指示能力不足已评定

重复性/再现/标准值范围：结果未提供或结果超出了规定值

结果的变异系数高，或无记录，或缺乏对每个项目的重复的分析

药品清单

Dopamine hydrochloride

0.2 & 3.2 mg/ml

Tirofiban

50 µg/ml

Famotidine

0.2 & 4 mg/ml

Tirofiban

50 µg/ml

Heparin sodium

40 & 100 UI/ml

Tirofiban

50 µg/ml

Lidocaine hydrochloride

1 & 20 mg/ml

Tirofiban

50 µg/ml

Potassium chloride

10 & 40 mEq/l

Tirofiban

50 µg/ml

Tirofiban

50 µg/ml	+ Dopamine hydrochloride	0.2 & 3.2 mg/ml	+
50 µg/ml	+ Famotidine	0.2 & 4 mg/ml	+
50 µg/ml	+ Heparin sodium	40 & 100 UI/ml	+
50 µg/ml	+ Lidocaine hydrochloride	1 & 20 mg/ml	+
50 µg/ml	+ Potassium chloride	10 & 40 mEq/l	+

25°C

Dopamine hydrochloride	0.1 & 1.6 mg/ml
Tirofiban	25 µg/ml

25°C

Famotidine	0.1 & 2 mg/ml
Tirofiban	25 µg/ml

25°C

Lidocaine hydrochloride	0.5 & 10 mg/ml
Tirofiban	25 µg/ml

25°C

Heparin sodium	20 & 50 UI/ml
Tirofiban	25 µg/ml

25°C

Potassium chloride	5 & 20 mEq/l
Tirofiban	25 µg/ml

Mentions Légales